zz zz
Chapterz z 1:z z Pharmacokinetics
Chapterzz2:zzDrug–
ReceptorzzInteractionszzandzzPharmacodynamicsz z Chapterzz3:z z The
z z AutonomiczzNervouszzSystem
Chapterzz4:zzCholinergiczzAgonistszzC
hapterzz5:zzCholinergiczzAntagonistszz
Chapterzz6:zzAdrenergiczzAgonistszzC
hapterzz7:zzAdrenergiczzAntagonists
Chapterzz8:zzDrugszzforzzNeurodegenerativezzDiseaseszzC
hapterzz9:zzAnxiolyticzzandzzHypnoticzzDrugs
Chapterzz10:zzAntidepressantszzChap
terzz11:zzAntipsychoticzzDrugszzChapt
erzz12:zzDrugszzforzzEpilepsyzzChapter
zz13:zzAnesthetics
Chapterz z 14:z z Opioids
Chapterzz15:zzDrugszzofzzAbusezzChap
terzz16:zzCNSzzStimulantszzChapterzz1
7:zzAntihypertensiveszzChapterzz18:zz
Diuretics
Chapterz z 19:z z Heartz z Failure
Chapterzz20:zzAntiarrhythmicszzChapt
erzz21:zzAntianginalzzDrugs
Chapterzz22:zzAnticoagulantszzandzzAntiplateletzzAgents
z z Chapterzz23:zzDrugszzforzzHyperlipidemia
Chapterzz24:zzPituitaryzzandzzThyroidzz
Chapterzz25:zzDrugszzforzzDiabetes
Chapterzz26:zzEstrogenszzandzzAndrogenszzChap
terzz27:zzAdrenalzzHormones
Chapterz z 28:z z Drugsz z forz z Obesity
Chapterzz29:zzDrugszzforzzDisorderszzofzzthezzRespiratoryzzSystemz z Ch
apterzz30:zzAntihistamines
Chapterzz31:zzGastrointestinalzzandzzAntiemeticzzDrugszz
Chapterzz32:zzDrugszzforzzUrologicz z Disorders
Chapterz z 33:z z Drugsz z forz z Anemia
Chapterzz34:zzDrugszzforzzDermatologiczzDisorderszzCha
pterzz35:zzDrugszzforzzBonezzDisorders
Chapterzz36:zzAnti-
inflammatory,zzAntipyretic,zzandz z AnalgesiczzAgentsz z Chapterzz37:z z Princip
leszzofz z Antimicrobialz z Therapy
Chapterz z 38:z z Cellzz Wallz z Inhibitors
Chapterz z 39:z z Proteinz z Synthesisz z Inhibitors
Chapterzz40:zzQuinolones,zzFoliczzAcidz z Antagonists,z z andz z Urinaryz z TractzzAntisepticszzC
hapterzz41:zzAntimycobacterialzzDrugs
Chapterzz42:zzAntifungalzzDrugszzCha
pterzz43:zzAntiprotozoalzzDrugszzChap
terzz44:zzAnthelminticzzDrugszzChapte
rzz45:zzAntiviralzzDrugs
Chapterz z 46:z z Anticancerz z Drugs
Chapterzz47:zzImmunosuppressantszz
Chapterzz48:zzClinicalzzToxicology
,Plusbay.Plus
,
, 3. The nurse is teaching a patient who will be discharged home with a prescription for an enteric
zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz
- coated tablet. Which statement by the patient indicates understanding of the teaching?
zz zz zz zz zz zz zz z z zz zz zz zz
a. I may crush the tablet and put it in applesauce to improve absorption.
zz zz zz zz zz zz zz zz zz zz zz zz
b. I should consume acidic foods to enhance absorption of this medication.
zz zz zz zz zz zz zz zz zz zz
c. I should expect a delay in onset of the drugs effects after taking the tablet.
zz zz zz zz zz zz zz zz zz zz zz zz zz zz
d. I should take this medication with high-
zz zz zz zz zz zz
fat foods to improve its action. ANS: C
zz zz zz zz zz zz zz
Enteric-
coated tablets resist disintegration in the acidic environment of the stomach and disintegrate w
zz zz zz zz zz zz zz zz zz zz zz zz zz
hen they reach the small intestine. There is usually some delay in onset of actions after taking t
zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz
hese medications. Enteric-
zz zz
coated tablets should not be crushed or chewed, which would alter the time and location of abs
zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz
orption. Acidic foods will not enhance the absorption of the medication. The patient should not
zz zz zz zz zz zz zz zz zz zz zz zz zz zz z
to eat high-fat food before ingesting an enteric-coated tablet, because high-
z zz zz zz zz zz zz zz zz zz zz
fat foods decrease the absorption rate.
zz zz zz zz zz
DIF: COGNITIVE LEVEL: Applying (Application) REF: dm 3 T
zz zz zz zz zz zz zz zz
OP: NURSING PROCESS: Nursing Intervention
zz zz zz zz
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
zz zz zz zz zz zz zz
4. A patient who is newly diagnosed with type 1 diabetes mellitus asks why insulin must be g
zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz
iven by subcutaneous injection instead of by mouth. The nurse will explain that this is because
zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz
a. absorption is diminished by the first-pass effects in the liver. zz zz zz zz zz zz zz zz zz
b. absorption is faster when insulin is given subcutaneously. zz zz zz zz zz zz zz
c. digestive enzymes in the gastrointestinal tract prevent absorption.
zz zz zz zz zz zz zz
d. the oral form is less predictable with more adverse effects.
zz zz zz zz zz zz zz zz zz
zz ANS: C zz
Insulin, growth hormones, and other protein-
zz zz zz zz zz
based drugs are destroyed in the small intestine by digestive enzymes and must be given parent
zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz
erally. Because insulin is destroyed by digestive enzymes, it would not make it to the liver for
zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz zz
metabolism with a first- zz zz zz
pass effect. Subcutaneous tissue has fewer blood vessels, so absorption is slower in such tissue.
zz zz zz zz zz zz zz zz zz zz zz zz zz zz
zz Insulin is given subcutaneously because it is desirable to have it absorb slowly.
zz zz zz zz zz zz zz zz zz zz zz zz
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: dm 3 T
zz zz zz zz zz zz zz zz
OP: NURSING PROCESS: Nursing Intervention: Patient Teaching
zz zz zz zz zz zz
Pagez z 2z z ofz z 507